PATP1280.03 – NeuroReset™ AI-Assisted Technical Review
At Biotech International Institute, NeuroReset™ is framed as a research-stage, patent-pending investigational platform built around a multi-site targeted conjugate design intended to explore recovery-related CNS biology. The technical review highlights its broader focus on neuroinflammation, post-dependency cognitive recovery, mood dysregulation, and relapse vulnerability, along with the underlying serotonergic / sigma-1 + CB2 mechanism logic and cleavable linker strategy.
Our new public-facing summary page is designed to make the platform easier to understand from a scientific and technical perspective, including:
mechanism framework
conjugate architecture
receptor selectivity logic
research-stage development focus
technical review context
The open page is intended for clarity, browser visibility, and stronger scientific communication.
More detailed AI-assisted technical review materials are available to qualified parties under NDA / CDA.
Research-stage. Patent-pending. Built for validation.
Mechanism first. Validation always.
